Event Brief
Moderna's Flu Vaccine Review by FDA Sparks Stock Surge
Filed: Feb 18, 2026 at 11:04 AM ET
Summary: Moderna's stock rises as FDA agrees to review its flu vaccine after initial refusal.
WHO: Moderna
WHAT: FDA review of flu vaccine candidate
WHEN: Feb 18, 2026 at 10:22 AM ET
WHERE: Location not specified
WHY: FDA changed its mind after concessions from Moderna
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →